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Background: There has been no documented data on the prevalence of allergic rhinitis among Filipino adults.
Objective: The objective of this study is to determine the prevalence of allergic rhinitis among adults in the Philippines.
Methods: Using a multi-staged cluster sampling methodology, this study evaluated 7,202 adults from 3,744 households, 79 provinces 
and 17 regions. A pre-validated written questionnaire for allergic rhinitis based on the International Study of Asthma and Allergies of 
Childhood was used as the survey instrument. 
Results: The response rate obtained from the interview was 94.1%. The overall prevalence of nose symptoms in the past 12 months 
was 20 % while prevalence of nose symptoms at any time in the past was 23.8%. The proportion among both sexes was similar. The 
prevalence was highest among the respondents 40-49 years old. The overall prevalence of nose and eye symptoms for the past twelve 
months was 14.0%. The prevalence of respondents who reported presence of nose problems for the past twelve months was similar 
across the 12 months of the year with highest rates noted in the months of June and May. Respondents from the rural area (22.1%) 
reported a higher prevalence of nose symptoms for the past twelve months compared to respondents from urban area (18%). There 
was no significant difference in prevalence of nose symptoms among residents living in coastal and/or inland areas. 
Conclusion: The overall prevalence of allergic rhinitis in the Philippines based on the 2008 National Nutrition and Health Survey is 
20.0%. 
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INTRODUCTION
Allergic rhinitis is characterized by one or more of the following 
symptoms: nasal itching, sneezing, watery nasal discharge and/
or nasal congestion. The symptoms result from the inflammatory 
reaction of the nose caused by the interplay of inflammatory cells 
and its mediators induced by exposure to allergens. 
It is a burdensome disease that affects patients of all ages. Aside 
from symptoms related to allergic rhinitis, patients often complain 
of fatigue, irritability, frustration, self-consciousness, having less 
energy and motivation, alertness and ability to concentrate. 
Likewise the presence of co-morbidities like asthma, otitis media 
and sinusitis also impacts on the quality of life of the patients. Thus 
the annual costs of treating asthma and allergic rhinitis, both direct 
costs (medications and hospitalization) and indirect costs (time 
lost from work, premature death) are substantial and can take 
their toll especially in a developing country like the Philippines. 
Approximately US$ 20 billion are spent globally each year in 
relation to allergic rhinitis which includes the cost of medications, 
lost work productivity and physician consultations [1]. This socio-
economic impact can be attributed to the increasing prevalence of 
allergic rhinitis. The 2008 State of the World Allergy Report stated 
that an estimated 400 million persons worldwide have allergic 
rhinitis [2]. In the US, allergic rhinitis affects 30-60 million people 
annually with the children more affected than adults [3]. Two large 
international studies namely the European Community Respiratory 
Health Survey and International Study of Asthma and Allergies of 
Childhood (ISAAC) Phase 1 have studied the prevalence of asthma 
and allergic rhinitis worldwide using standardized questionnaires. 
Results showed variation in prevalence between centers and 
regions with highest prevalence (>30%) reported mainly in the 
centers from middle and low income countries, particularly in 
Africa and Latin America. Other areas with high prevalence of 
rhinitis were Australia, New Zealand, United Kingdom and Hong 
Kong. The lowest prevalence of rhinoconjunctivitis (<5%) were 
found in parts of Eastern Europe, Indonesia, Greece, China, Taiwan, 
Uzbekistan, India, and Ethiopia [2].
In Asia, a rising trend in the prevalence of allergic rhinitis and 
asthma was observed, particularly in low to middle-income 
countries according to the epidemiologic data from the ISAAC 
phase III. According to the 2008 World Allergy Report [2], the 
estimated prevalence of allergic rhinitis among adults in the Asia 
Pacific region was between 10% and 32%. 
In 1996, the Philippines which participated in the ISAAC survey 
had a reported 26-32% prevalence of allergic rhinitis among 
subjects aged 13-14 years [4, 5]. In 2003, during the 6th National 
Health and Nutrition Survey (NNHeS), the prevalence of allergic 
rhinitis among adults 20 years and above using the ISAAC core 
questionnaire was 26.8% (unpublished data). However the survey 
was conducted only within Metro Manila. Since then, there has 
been little information regarding the nationwide prevalence of 
allergic rhinitis in the Philippines. In 2008, NNHeS conducted a 
nationwide survey on the prevalence of leading diseases including 
atopic diseases. This article reports the prevalence of allergic 
rhinitis in adults nationwide.
MATERIALS AND METHODS
Sampling design of National Nutrition Survey (NNS)
The 7th (2003) NNS utilized the National Statistics Office 2008 
Labor Force Survey master sample employing a stratified multi-
stage sampling design in order to represent each of the 17 regions 
in the country. The first stage of the sampling was the selection of 
the Primary Sampling Units (PSUs) with probability proportional 
to the estimated number of households. PSUs consisted of a 
barangay or contiguous barangays with at least 500 households. 
The second stage was the selection of Enumeration Areas (EAs) 
within sampled PSUs with the probability proportional to size. 
EAs consisted of contiguous area in a barangay or a barangay 
with 150-200 households and served as the Secondary Sampling 
Unit. The last stage was the selection of housing units within the 
sampled EAs and served as the ultimate sampling unit. As such, 
the household was considered as a cluster in which all the units 
within a cluster were part of the survey. The clinical and health 
component in particular covered only one of the four replicates 
of the master sample and 25 percent of sample households 
were considered as sub-sample. Sub-sampling of households for 
clinical and health component was resorted due to budgetary 
constraints. A replicate is defined as a sub-sample that possesses 
the properties of the full master sample such that each replicate is 
able to generate national level estimates of adequate precision. 
According to the National Statistic Coordinating Board, the 
following are the definitions of topography and location of 
respondents. 
Based on topography there were three recorded variables:
1.   Inland which included those respondents from inland regions 
(plain, mountainous, agricultural, plain mountainous, plain apallergy.org
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agricultural, mountainous agricultural)
2. Coastal areas (coastal, plain coastal) 
3. Combination of inland and coastal. 
  Based on location, “urban” areas fall under the following 
categories:
1.    In their entirety, all municipal jurisdictions which, whether 
designated chartered cities, provincial capital or not, have 
a population density of at least 1,000 persons per square 
kilometer: all barangays;
2.   Poblaciones or central districts of municipalities and cities 
which have a population density of at least 500 persons square 
kilometer; 
3.     Poblaciones or central districts not included in (1) and (2) 
regardless of the population size which have the following:
•   Street pattern or network of streets in either parallel or right 
angle orientation; 
•   At least six establishments (commercial, manufacturing, 
recreational and/or personal services); 
•   At least three of the following: 
-   A town hall, church or chapel with religious service at least 
once a month; a public plaza, park or cemetery; 
-   A market place, or building, where trading activities are 
carried on at least once a week; 
-   A public building, like a school, hospital, puericulture and 
health center or library. 
4.   Barangays having at least 1,000 inhabitants which meet the 
conditions set forth in (3) above and where the occupation of 
the inhabitants is predominantly non-farming or fishing. 
“  Rural” areas are defined as all poblaciones or central districts 
and all barrios that do not meet the requirements for 
classification of urban. 
Questionnaires
The NNHeS survey instrument used for the diagnosis of rhinitis 
was a standardized questionnaire that was validated locally. This 
questionnaire contained 4 items from a pre-validated ISAAC 
screening instrument for nose problems among children and 
adolescents [6]. Based on the questionnaire, rhinitis was described 
as “a problem with sneezing” or “a runny or blocked nose”. 
Concurrent validity of the core questionnaire was determined 
in the SCARPOL study. The core questionnaire was tested by 
comparing them with results of skin test among Swiss children 
[7]. Results showed that the specificity of the questions was high 
(77.5-97.6%) but sensitivity was low (2.6-42.7%). 
Prior to the survey, the core questionnaire was pretested among 
residents of Bicutan, Taguig City, Metro Manila in April 2008. 
This was performed in order to test the correctness, clarity, time 
requirement and suitability of each question before the booklets 
were finalized and reproduced. The survey questionnaire was also 
approved by the Ethics and Clearance Committee of the National 
Statistical Coordination Board. 
Data collection 
Face-to-face interview on various questions on selected signs 
and symptoms including clinical histories to elicit information 
regarding other non communicable diseases such as “bangungot” 
(sudden unexpected cardiac death in the Philippines), peripheral 
vascular disease, cardiovascular disease, chronic kidney disease, 
hyperuricemia, microalbuminuria, musculoskeletal disease, 
osteoporosis, asthma, rhinitis, and allergy. In addition, lifestyle 
risk factors such as smoking, alcohol intake, physical inactivity 
and diet were included. A guide for interviewing was taken into 
consideration in the conduct of face-to-face interview developed 
by the FNRI-DOST.
Data editing, encoding and analysis 
All team leaders conducted field data editing based on the 
manual of instructions to ensure correctness, completeness 
and validity of collected data. Team coordinators, on the other 
hand, performed spot checking of accomplished forms as part 
of field editing process in order to reduce errors in data entry. 
Simultaneously with data collection, data encoding was done by 
hired encoders at FNRI-DOST. 
Data encoding used the MySQL database. To ensure correctness 
and validity of data, a two-round proofreading of the databases 
was done by hired validators. The first-round involved manual 
validation and the second was done through machine validation. 
When the data were cleaned, several data files were merged 
to create a master dataset followed by another checking and 
validation of the dataset to eliminate errors and inconsistencies. 
Weights were assigned and attached to the master dataset by a 
statistician in order that the distributions of the sample correspond 
more closely to their actual distributions in the whole population.
Stata software (StataCorp., USA) was used to process and analyze 
the clinical and health data to come up with the prevalence of 
disease and risk factors according to age. apallergy.org
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RESULTS
In the 7th NNS Clinical and Health Component, a total of 3,744 
eligible households were covered from 79 provinces and 3,377 
EAs. The response rate obtained from interview of adults using the 
questionnaires was 93.7%. The survey covered all respondents of 
the randomly selected households consisting of 7,202 subjects 20 
years old and above, 54% (3,885) were females and 46% (3,317) 
were males.
The overall prevalence of nose symptoms at any time in the past 
was 23.8%. The proportion among both sexes was similar. The 
prevalence was highest among the respondents aged 40-49 (Table 
1). 
Twenty percent reported nose symptoms in the past 12 months. 
The proportion of respondents who reported nose symptoms in 
the past 12 months was also similar between males and females 
and was likewise noted to be highest in the 40-49 age group (Table 
1).
Nose as well as eye problems were also reported according 
to age group and sex. The over-all prevalence of nose and eye 
symptoms was 14.0% The over-all prevalence of nose and eye 
symptoms in the past 12 months showed a statistically significant   
difference across age groups with respondents in 40-49 and 70 & 
over age group having the highest prevalence at 15.3 and 16.5% 
respectively (Table 1).
Respondents from the rural area reported a higher prevalence 
of nose symptoms in the past twelve months compared to 
respondents from the urban area (p value 0.0519) (Table 2).
The prevalence of nose problems in the past 12 months was 
similar among respondents regardless of topographical area of 
residence (Table 3). and was likewise similar across the 12 months 
of the year with highest rates noted in the months of June and 
May (Fig. 1). 
DISCUSSION
Although not a life threatening disease, allergic rhinitis 
significantly reduces the quality of life of sufferers leading to 
employee absenteeism and presenteeism (loss of productivity 
at work). Approximately US$ 20 billion are spent globally each 
year in relation to allergic rhinitis, which includes the cost of 
medications, lost work productivity and physician consultations [1]. 
Table 1. Prevalence of nose and/or eye symptoms by age, Philippines, 2008
Age
With nose symptoms 
at anytime
*
With nose symptoms 
for the past 12 months
†
With nose & eye symptoms 
for the past 12 months
†
n % (SE) n % (SE) n % (SE)
20-29 1,737 22.5 (1.2) 1,737 18.4 (1.0) 919 23.5 (1.6)
30-39 1,644 24.0 (1.3) 1,644 20.5 (1.2) 886 23.9 (1.6)
40-49 1,550 25.4 (1.3) 1,550 22.0 (1.2) 804 25.0 (1.6)
50-59 1,102 22.9 (1.4) 1,102 18.5 (1.3) 608 23.3 (1.8)
60-69     711 24.3 (1.8)    711 20.2 (1.8) 400 23.2 (2.3)
70 & over     458 24.4 (2.2)    458 20.1 (2.0) 268 24.6 (2.8)
Overall 7,202 23.8 (0.7) 7,202 20.0 (0.7) 3885 23.9 (0.9)
*Not significantly different across age groups.
 †Significantly different across age groups. 
Table 2. Prevalence of nose symptoms for the past twelve months, by area of residence, age and sex, Philippines, 2008
Area of residence
With nose symptoms for the past twelve months
Both sexes Males Females
n % (SE) n % (SE) n % (SE)
Urban 3,418 18.0 (0.9) 1,508 17.2 (1.2) 1,910 18.5 (1.1)
Rural 3,784 22.1 (1.0) 1,809 22.3 (1.2) 1,975 22.0 (1.2)
p-values 0.0519 0.1064 0.2177apallergy.org
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Improvement in identification of risk factors and triggers, health 
care delivery, public awareness, appropriate management and 
implementation of preventive measures are needed to improve 
the quality of life of allergic patients. One of the initial steps 
towards attaining this goal is a prevalence survey to assess the 
burden of illness and its economic impact. 
In 2008, the reported prevalence of allergic rhinitis worldwide 
was 10-30% while in the Asia Pacific region, the prevalence ranged 
from 10 to 32% in adults [2]. The prevalence is still increasing 
worldwide. However, prevalence reports in the Philippines among 
adults are scarce. Literature search covering the past 20 years 
showed only one prevalence report from the ISAAC study [4]. 
In 1996, the Philippines was one of the 38 countries in Europe, 
Africa and Asia-Pacific that participated in the ISAAC study. Results 
showed that Filipinos in Metro Manila aged 13-14 years had one of 
the highest prevalence rates of allergic rhinitis at 32.5% [4]. During 
the 2003 6th NNHeS survey, the reported prevalence of allergic 
rhinitis based on nose problems in the past 12 months among 
Filipinos in the National Capital Region (NCR) ages 20 and above 
was 26.8% (6-35%). The highest prevalence was reported among 
the 30-39 age group. In 2009, another survey was conducted by 
the NHES among residents 40 years and above in the NCR using 
the same ISAAC core questionnaire. Result of the unpublished data 
showed that the overall prevalence of allergic rhinitis based on 
nose problems in the past twelve months was 16.3%.
In the 2008 NNHeS survey the estimated over-all prevalence of 
allergic rhinitis based on nose symptoms in the past 12 months 
(sneezing, or any runny, blocked nose in the absence of cold or the 
flu) and at any time in the past were 20% and 23.8% respectively. 
The results showed that the nationwide prevalence of rhinitis is 
within the range of rhinitis prevalence in the Asia Pacific region [2]. 
However comparison of the present survey with previous 
epidemiologic surveys done locally such as the 1996 ISAAC, the 
2003 and 2009 NNHeS may prove to be inaccurate for several 
reasons. Although the 1996 ISAAC report, the 2003, 2008 and 
2009 NNHeS survey utilized the same rhinitis definition and 
questionnaire (ISAAC core questionnaire), they differed in the 
age group of the subjects and the geographic areas surveyed. 
The 1996 ISAAC survey, the 2003 and 2009 NNHeS survey were 
conducted in MetroManila and the NCR respectively, involving 
subjects from different age groups. The ISAAC surveyed teens 
13-14 years old while the 2003 NNHeS survey included all adults 
20 years and above. The 2009 survey included only residents 40 
years old and above. On the other hand the present survey (2008), 
using the ISAAC core questionnaire was expanded to include all 
adult patients ages 20 and above, nationwide. The difference in 
the choice of subjects in terms of age and location are important 
factors that may contribute significantly to the different outcome 
of the surveys. A more logical and useful approach is to compare 
longitudinal studies using the same method at different periods of 
time.
The prevalence of nose symptoms within the past 12 months 
was 20.0%. When nose and eye symptoms were combined, the 
prevalence rate was 14%. Allergic rhinitis is often accompanied by 
allergic conjunctivitis (a disease complex sometimes referred to as 
allergic rhinoconjunctivitis) that produces conjunctival injection 
Table 3. Prevalence of nose symptoms in the past twelve months by age and sex and topography, Philippines, 2008
Topography
With nose symptoms in the past 12 months
Both sexes Males Females
n % (SE) n % (SE) n % (SE)
Inland 5,553 20.4 (0.7) 2,569 20.1 (0.9) 2,983 20.5 (0.9)
Coastal   973 21.1 (1.8)   425 20.5 (2.4)    548 21.6 (2.0)
Combination   673 14.9 (1.7)   322 15.6 (2.3)    351 14.3 (2.0)
p-values 0.0563 0.4959 0.0765
Fig. 1. Prevalence of nose symptoms by months of the year, 2008, 
Philippines. Not significantly different across months of the year. 
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and chemosis associated with symptoms of itchy eyes and tearing. 
Sensitivity to pollens is more frequently seen in patients with 
rhinoconjunctivitis, whereas sensitivity to dust mites is reported to 
cause less ocular symptoms [6].
The present survey also showed that the prevalence of nose 
symptoms was similar across the 12 months of the year indicating 
the perennial nature of the nose problem in the Philippines. 
Perennial rhinitis is more commonly observed in tropical countries 
like the Philippines while seasonal allergic rhinitis is more evident 
in temperate countries where the four seasons are experienced. 
Common aeroallergens that sensitize patients with perennial 
allergic rhinitis are indoor allergens that are present throughout 
the year such as house dust mite. According to the study of Dr. 
Cua-Lim [7] in 1994 and unpublished observations of Dr. Distor 
in 2005, the most common allergens to sensitize Filipino patients 
were house dust mite and cockroach which are indoor allergens 
present throughout the year.
Aside from allergens, perennial rhinitis may also be attributable 
to exposure to irritant pollutants. Although there is a downward 
trend demonstrated in the levels of Total Suspended Particles (TSP) 
from 2003-2007, from 144 to 97 μgm/Ncu.m., TSP geometric mean 
concentrations are still above the 90 μg/Ncu.m annual mean TSP 
guideline value for one year [8]. Other diseases with symptoms 
that overlap with allergic rhinitis are sinusitis, respiratory infections 
and vasomotor rhinitis. 
Studies in North America, Europe and Central America have 
shown a higher prevalence of allergic rhinitis in urban than in rural 
areas [9]. However in the present survey, the respondents from the 
rural area reported a higher prevalence of nose symptoms for the 
past twelve months compared to respondents from urban area. 
This variation in rates may be due to differences in risk factors and 
triggers present in different geographical areas [9].
The high prevalence noted in the elderly is not consistent with 
the natural history of allergic rhinitis. In general, symptoms of 
allergic rhinitis tend to improve and skin test reactivity slowly 
disappears with increasing age [10]. Problems encountered in 
surveys using questionnaires may account for these results. It 
has been observed that in surveys using rhinitis questionnaire, 
around 50-60% of non allergic rhinitis and rhino sinusitis have 
been attributed to allergy [11]. Non-allergic rhinitis such as irritant 
and atrophic rhinitis are commonly experienced by the elderly 
that can be mistaken for allergic rhinitis. The elderly population 
is also susceptible to medication related rhinitis considering the 
wide array of medications prescribed for age related diseases and 
co-morbidities [9]. Patients may exaggerate symptoms of rhinitis 
while some may dismiss or ignore these symptoms.
An inherent problem in wide epidemiologic surveys using 
questionnaires is the failure to comply with the strict definition 
of allergic rhinitis [11]. This is one limitation of our survey. It is 
difficult especially in terms of logistic and manpower resources, to 
obtain laboratory or objective evidence of allergic response (e.g. 
skin test) or for physicians and specialists to visit our respondents 
individually considering the epidemiologic setting involving a large 
population nationwide. Hence, the figures obtained in prevalence 
studies may be an exaggeration of the actual prevalence. On the 
other hand, the reported specificity of the core questionnaire 
during validation in the SCARPOL study was high (77.5% to 97.6%), 
which makes it useful for ruling out but not helpful in detecting 
atopy since the sensitivity is low (2.6% to 42.7%). This may lead to 
an underestimation of the prevalence [12].
The potential for over- or under-estimation of prevalence rates 
in wide epidemiologic surveys is a well-recognized limitation. 
However, what is deemed more important in these types of 
surveys is to have a standard epidemiologic tool (eg. definition of 
rhinitis, asthma, etc.), which may be utilized across nations. This will 
allow a more meaningful and relevant comparison of prevalence 
rates worldwide. 
In the past, allergic rhinitis was generally considered to be a 
trivial condition. However, more recent reports recognize the 
substantial impact it has on the socio-economic realm as well as 
on the quality of life of patients with allergic rhinitis. Knowing the 
trends in the prevalence of allergic diseases can assist stakeholders 
in mapping out health policies and plans, in improving access to 
medical care and in achieving better control of symptoms, thus 
eventually improvement the quality of life of our patients.
In conclusion, the over-all prevalence of allergic rhinitis in 
Filipino adults in this study is 20%. This value is considered to be 
within the range of the reported prevalence rates in the Asia-
Pacific Region. 
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